Insufficient scRNA-seq data for expression of IRX5 at single-cell level.
Insufficient scRNA-seq data for expression of IRX5 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 85% | 1859.54 | 388 / 459 | 99% | 73.15 | 1108 / 1118 |
skin | 100% | 1389.89 | 1803 / 1809 | 60% | 6.71 | 283 / 472 |
prostate | 83% | 433.88 | 203 / 245 | 65% | 5.97 | 324 / 502 |
lung | 71% | 340.70 | 412 / 578 | 66% | 11.84 | 758 / 1155 |
kidney | 58% | 254.70 | 52 / 89 | 54% | 14.13 | 487 / 901 |
esophagus | 38% | 273.57 | 554 / 1445 | 64% | 10.65 | 118 / 183 |
stomach | 61% | 215.82 | 220 / 359 | 17% | 2.22 | 49 / 286 |
uterus | 1% | 5.45 | 2 / 170 | 64% | 13.12 | 292 / 459 |
tonsil | 0% | 0 | 0 / 0 | 64% | 7.67 | 29 / 45 |
blood vessel | 48% | 90.07 | 640 / 1335 | 0% | 0 | 0 / 0 |
heart | 43% | 362.27 | 373 / 861 | 0% | 0 | 0 / 0 |
adipose | 42% | 111.19 | 509 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 39% | 2.80 | 31 / 80 |
ovary | 5% | 7.51 | 9 / 180 | 31% | 7.33 | 132 / 430 |
brain | 24% | 49.98 | 636 / 2642 | 11% | 1.20 | 78 / 705 |
bladder | 5% | 7.10 | 1 / 21 | 22% | 3.74 | 110 / 504 |
muscle | 23% | 47.57 | 186 / 803 | 0% | 0 | 0 / 0 |
adrenal gland | 12% | 20.74 | 30 / 258 | 11% | 1.15 | 26 / 230 |
pancreas | 0% | 0.43 | 1 / 328 | 15% | 1.54 | 27 / 178 |
intestine | 0% | 0.40 | 2 / 966 | 12% | 1.27 | 63 / 527 |
thymus | 0% | 0.54 | 2 / 653 | 4% | 0.72 | 24 / 605 |
liver | 0% | 0 | 0 / 226 | 2% | 0.19 | 8 / 406 |
peripheral blood | 0% | 0.30 | 1 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0048701 | Biological process | embryonic cranial skeleton morphogenesis |
GO_0007601 | Biological process | visual perception |
GO_0030182 | Biological process | neuron differentiation |
GO_0008406 | Biological process | gonad development |
GO_0048468 | Biological process | cell development |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0005499 | Molecular function | vitamin D binding |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0140297 | Molecular function | DNA-binding transcription factor binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
Gene name | IRX5 |
Protein name | Iroquois-class homeodomain protein IRX-5 (Homeodomain protein IRX-2A) (Homeodomain protein IRXB2) (Iroquois homeobox protein 5) Iroquois homeobox 5 IRX5 protein |
Synonyms | IRXB2 IRX2A |
Description | FUNCTION: Establishes the cardiac repolarization gradient by its repressive actions on the KCND2 potassium-channel gene. Required for retinal cone bipolar cell differentiation. May regulate contrast adaptation in the retina and control specific aspects of visual function in circuits of the mammalian retina (By similarity). Could be involved in the regulation of both the cell cycle and apoptosis in prostate cancer cells. Involved in craniofacial and gonadal development. Modulates the migration of progenitor cell populations in branchial arches and gonads by repressing CXCL12. . |
Accessions | P78411 ENST00000560154.5 H0YML8 A2RRB5 ENST00000394636.9 [P78411-1] ENST00000320990.9 [P78411-2] |